Literature DB >> 8562243

Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.

S Dubrey1, A Pollak, M Skinner, R H Falk.   

Abstract

Thrombus formation in the left atrium is rare in patients in sinus rhythm. In three patients with extensive cardiac amyloidosis transthoracic echocardiography showed large atrial thrombi in or protruding into the body of the left atrium during sinus rhythm. Doppler studies showed no A wave on mitral inflow. Severe atrial and ventricular infiltration by amyloid may have resulted in mechanical atrial standstill with resultant thrombus formation. These findings suggest that patients with severe cardiac amyloidosis may require anticoagulation when atrial function is impaired.

Entities:  

Mesh:

Year:  1995        PMID: 8562243      PMCID: PMC484078          DOI: 10.1136/hrt.74.5.541

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  14 in total

1.  [An autopsy case of primary amyloidosis with huge thrombi in both the right and left atrium].

Authors:  T Nakano; Y Futagami; T Konishi; H Takezawa
Journal:  Nihon Naika Gakkai Zasshi       Date:  1986-09

2.  Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients.

Authors:  W C Roberts; B F Waller
Journal:  Am J Cardiol       Date:  1983-07       Impact factor: 2.778

3.  The influence of left ventricular filling pressure on atrial contribution to cardiac output.

Authors:  B Greenberg; K Chatterjee; W W Parmley; J A Werner; A N Holly
Journal:  Am Heart J       Date:  1979-12       Impact factor: 4.749

4.  Amyloid heart disease manifested by systemic arterial thromboemboli.

Authors:  R S Browne; H Schneiderman; N Kayani; M J Radford; W D Hager
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

5.  Non-rheumatic atrial fibrillation as a risk factor for stroke.

Authors:  M Britton; C Gustafsson
Journal:  Stroke       Date:  1985 Mar-Apr       Impact factor: 7.914

6.  Roles of echocardiography and arrhythmia monitoring in the evaluation of patients with suspected systemic embolism.

Authors:  P C Come; M F Riley; N K Bivas
Journal:  Ann Neurol       Date:  1983-05       Impact factor: 10.422

7.  Embolic complications in paroxysmal atrial fibrillation.

Authors:  P Petersen; J Godtfredsen
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

Review 8.  Doppler echocardiographic assessment of constrictive pericarditis, cardiac amyloidosis, and cardiac tamponade.

Authors:  A L Klein; G I Cohen
Journal:  Cleve Clin J Med       Date:  1992 May-Jun       Impact factor: 2.321

9.  Doppler characterization of left ventricular diastolic function in cardiac amyloidosis.

Authors:  A L Klein; L K Hatle; D J Burstow; J B Seward; R A Kyle; K R Bailey; T F Luscher; M A Gertz; A J Tajik
Journal:  J Am Coll Cardiol       Date:  1989-04       Impact factor: 24.094

10.  Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study.

Authors:  A L Klein; L K Hatle; C P Taliercio; J K Oh; R A Kyle; M A Gertz; K R Bailey; J B Seward; A J Tajik
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  26 in total

1.  Repeated systemic thromboembolism in a patient with severe cardiac AL amyloidosis without evidence of atrial fibrillation.

Authors:  Francesco Cappelli; Luigi Padeletti; Manlio Acquafresca; Alberto Moggi Pignone; Federico Perfetto
Journal:  Intern Emerg Med       Date:  2013-05-28       Impact factor: 3.397

2.  The physics of left ventricular filling: exploring the seemingly obvious.

Authors:  F A Flachskampf; P Hanrath
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

3.  Role of echocardiography in assessing cardiac amyloidoses: a systematic review.

Authors:  Jun Koyama; Masatoshi Minamisawa; Yoshiki Sekijima; Koichiro Kuwahara; Tsutomu Katsuyama; Kazutoshi Maruyama
Journal:  J Echocardiogr       Date:  2019-02-11

Review 4.  Cardiac amyloidosis: the heart of the matter.

Authors:  Federico Perfetto; Francesco Cappelli; Franco Bergesio; Gabriele Ciuti; Maria Cristina Porciani; Luigi Padeletti; Alberto Moggi Pignone
Journal:  Intern Emerg Med       Date:  2011-07-08       Impact factor: 3.397

5.  Atrial Cardiopathy and Cryptogenic Stroke: A Cross-sectional Pilot Study.

Authors:  Shadi Yaghi; Amelia K Boehme; Rebecca Hazan; Eldad A Hod; Alberto Canaan; Howard F Andrews; Hooman Kamel; Randolph S Marshall; Mitchell S V Elkind
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-10-21       Impact factor: 2.136

6.  Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis.

Authors:  Edward A El-Am; Angela Dispenzieri; Rowlens M Melduni; Naser M Ammash; Roger D White; David O Hodge; Peter A Noseworthy; Grace Lin; Sorin V Pislaru; Alexander C Egbe; Martha Grogan; Vuyisile T Nkomo
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

Review 7.  Transthyretin Cardiac Amyloidosis in Black Americans.

Authors:  Keyur B Shah; Anit K Mankad; Adam Castano; Olakunle O Akinboboye; Phillip B Duncan; Icilma V Fergus; Mathew S Maurer
Journal:  Circ Heart Fail       Date:  2016-06       Impact factor: 8.790

Review 8.  Transthyretin Cardiac Amyloidosis.

Authors:  Anit K Mankad; Keyur B Shah
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

9.  Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.

Authors:  S W Dubrey; K Cha; M Skinner; M LaValley; R H Falk
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

Review 10.  Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.

Authors:  Adam Castaño; Brian M Drachman; Daniel Judge; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.